Skip to main content

Client News

QUANTRO Therapeutics and IMP enter into research collaboration to accelerate transcriptomic drug discovery

24th October 2024

SLS Europe and Bilthoven Biologicals receive positive CHMP Opinion for SIILTIBCY® – a Novel Tuberculosis Skin Test in Europe

23rd October 2024

HepaRegeniX appoints Dr. Martin Bonde as new Chair of the Board

22nd October 2024

LINDIS Biotech receives Positive CHMP Opinion for KORJUNY® (catumaxomab) in the European Union

21st October 2024

Mainz Biomed Reports Mid-Year 2024 Financial Results and Provides Corporate Update

21st October 2024

Medigene AG Presents UniTope and TraCR a Universal Detection System for 3S Recombinant TCRs at ASGCT 2024

17th October 2024

Formycon Published Results of Analytical Similarity Study of Biosimilar Candidate FYB206 and Keytruda®1 in Peer-Reviewed Journal Drugs in R&D

16th October 2024

invIOs Raises €8.2 Million in a Series A to Finance Pipeline Progress in Immuno-Oncology

15th October 2024

Affluent Medical Announces Participation in Upcoming Scientific Events

8th October 2024

Nyxoah Raises $27 Million through its At-the-Market Offering

8th October 2024